Agent for prophylaxis and treatment of cardiac hypertrophy

Details Agent for prophylaxis and treatment of cardiac hypertrophy Agent for prophylaxis and treatment of cardiac hypertrophy

1987-12-09

1989-12-19

Willis, Prince E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514398, 548321, A61K 31415, C07D23338

Patent

active

048883395

ABSTRACT:
Novel agent for the propylaxis and treatment of heart failure, which comprises as an active ingredient a 2-oxo-imidazolidine compound of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and are each a lower alkyl group, R.sup.3 is a phenyl-substituted lower alkyl group, and R.sup.4 is a hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4416895 (1983-11-01), Thorogood
patent: 4508727 (1985-04-01), Yoneda et al.
patent: 4587258 (1986-05-01), Gold et al.

Affiliated with

Also associated with

Rating

Agent for prophylaxis and treatment of cardiac hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for prophylaxis and treatment of cardiac hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for prophylaxis and treatment of cardiac hypertrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1903041